Weill Cornell Medicine | NewYork-Presbyterian
425 East 61st Street
New York, New York 10065

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Relapsed/Refractory Locally Advanced or Metastatic Breast Cancer and Triple Negative Breast Cancer Clinical Trial
Safety Study of MELK Inhibitor to Treat Patients With Advanced Breast Cancer and Triple Negative Breast Cancer
Status: Enrolling, Phase I
Updated: 12/31/1969
Weill Cornell Medicine | NewYork-Presbyterian
mi
from
New York, NY
Click here to add this to my saved trials